Healthcare is embracing AI for better diagnosis, drug development, and patient care. AI can outperform doctors in tasks like tumor detection and streamline clinical trials. This technology has the potential to save billions in healthcare costs. AI's potential in healthcare is undeniable, but its real-world impact on patient care is unclear. Despite limited evidence and concerns raised by studies, the FDA is approving AI tools, and experts predict wider adoption as more data emerges.[1]
Many clinical trials fail due to poor data management, regulation issues, and trouble meeting goals. Delays and patient non-adherence are additional hurdles. However, AI, big data, and other emerging technologies offer promise. These tools can improve data management, identify suitable patients, and monitor trials in real-time. The growing demand for AI-powered solutions from CRO companies like AiCure, Antidote Technologies, Deep 6 AI, Intel, IQVIA, Medidata, Mendel.ai, Phesi, Saama Technologies, and Signant Health suggests a future where these tools become essential for efficient drug development.[2]
AiCure, a US-based advance analytics company leverages AI to improve both clinical trials and personalized healthcare. Their focus in clinical trials is on patient-centricity through their AiCure Patient Connect app. This app offers features like real-time medication reminders, adherence monitoring, and secure communication channels to reduce patient burden and improve experience. Beyond the patient experience, AiCure offers a suite of AI-powered tools for trial organizers, including real-time data analysis, site selection, and patient/trial monitoring. They even have tools for personalizing treatment plans and optimizing workflows across traditional, decentralized, and hybrid trials. With a global reach (over 30 countries) and a vast arsenal of AI tools (65+ proprietary technologies), AiCure is a leader in this space. Recent developments include launching clinical site services (Sept. 2022) and participating in a PTSD trial (Jan. 2023) which is ongoing. AiCure is on a mission to unlock the full potential of digital biomarkers. To achieve this, they're looking to explore the wide range of uses for these AI-powered algorithms. They believe that by collaborating with a broader community, they can gain valuable insights and perspectives that will fuel the development of even better digital biomarkers.[3]
Antidote a US based digital health company, is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies. Antidote offers comprehensive clinical trial patient recruitment services, tailored to each study's specific needs. They leverage a vast network of 300+ partners and an AI-powered online platform to reach potential patients. Patients can opt-in to trials that match their profile. Antidote then conducts a pre-screening process to ensure eligibility. Qualified patients are registered and their information validated to meet study requirements. Lab validations can be performed as needed. Finally, Antidote follows up with clinical trial sites to ensure a smooth transition for enrolled patients. More recently news about antidote is in their partnering with Melanoma Research Alliance (MRA) to improve the clinical trial search experience for melanoma patients and caregivers. Melanoma is a growing concern, with 100,000 new cases diagnosed annually in the US alone. The collaboration focuses on enhancing MRA's Clinical Trial Navigator platform, powered by Antidote Match. Key improvements include personalized user flows, expanded information on rare subtypes, and options for patients in early disease stages. This initiative reflects their commitment to user centric design and making clinical trial searches efficient and relevant. [4]
Deep 6 AI is a US based data mining company with a focus to speed up Clinical Trials with AI. Deep 6 AI is a leader in AI-powered clinical trial software. They connect researchers, patients, and trial sites in a real-time ecosystem. Their key strength is using AI to analyze patient data, including doctors' n...
(All Rights Reserved)